Olfactory absorption of insulin to the brain

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 4, Issue 3, 1997, Pages 195-200

  Sigurdsson, Páll ^a   Thorvaldsson, Tryggvi ^a   Gizurarson, Sveinbjörn ^a   Gunnarsson, Eggert ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Absorption; Brain; Insulin drug delivery; Olfactory

Indexed keywords

INSULIN; IODINE 125;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG TRANSPORT; FEMALE; HYPERINSULINEMIA; IMMUNE DEFICIENCY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; OLFACTORY EPITHELIUM; PH; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

EID: 0030875315     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549709051892     Document Type: Article

References (35)

1. Adamo, M., Raizada, M. K., and LeRoith, D. 1989. Insulin and insulin-like growth factor receptors in the nervous system. Mol Neurobiol. 3:71-100.
2. Allison, R. R., and Stach, P. E. 1978. Intrathecal drug therapy. Drug Intellig. Clin. Pharm. 12:347-359.
3. Baura, G. D., Foster, D. M., Porte, D. Jr., Kahn, S. E., Bergman, R. N., Cobelli, R. N., Cobelli, C., and Schwartz, M. W. 1993. Saturable transport of insulin from plasma into the central nervous system in dogs in vivo. J. Clin. Invest. 92:1824-1830.
4. Brange, J. 1987. Galenics of Insulin. The Physico-Chemical and Pharmaceutical Aspects of Insulin and Insulin Preparations. Berlin: Springer-Verlag.
5. 198Au from nasal mucous membrane into cerebrospinal fluid. Acta Otolaryng. 70:58-61.
6. De Vries, H. E. 1995. Characteristics of Blood-Brain Barrier Endothelial Cells in Response to Inflammatory Stimuli. CIP Koninklijke bibliotheek, Haag, The Netherlands, PhD thesis.
7. Evans, J., and Hastings, L. 1992. Accumulation of Cd(II) in the CNS depending on the route of administration: Intraperitoneal, intratracheal or intranasal. Fundam. Appl. Toxicol. 19:275-278.
8. Friden, P. M., Walus, L. R., Watson, P., Doctrow, S. R., Kozarich, J. W., Bäckman, C., Bergman, H., Hoffer, B., Bloom, F., and Granholm, A. C. 1993. Blood-brain barrier penetration and in vivo activity of a NGF conjugate. Science 259:373-377.
9. Gizurarson, S., and Bechgaard, E. 1991. Study of nasal enzyme activity towards insulin in vitro. Chem. Pharm. Bull. 39:2155-2157.
10. Gizurarson, S., Sigurdsson, P., Thorvaldsson, T., and Gunnarsson, E. 1995. Technique for administering drugs to the brain and bypassing the blood-brain barrier. Scand. J. Lab. Anim. Sci. 22:273-276.
11. Gizurarson, S., Thorvaldsson, T., Sigurdsson, P., and Gunnarsson, E. 1996. Selective delivery of insulin to the brain. Intraolfactory absorption. Int. J. Pharm. 140:77-83.
12. Hirai, S., Ikenaga, T., and Matsuzawa, T. 1978. Nasal absorption of insulin in dogs. Diabetes 27:296-299.
13. Hökfelt, T. 1991. Neuropeptides in perspective: The last ten years. Neuron 7:867-879.
14. Jackson, R. T., Tigges, J., and Arnold, W. 1979. Subarachnoid space of the CNS, nasal mucosa and lymphatic system. Arch. Otolaryngol. 105:180-184.
15. Jeanrenaud, B., Rohner-Jeanrenaud, F., Cusin, I., Zarjevski, N., Assimacopoulos-Jeannet, F., Guillaume-Gentil, C., Bchini Hooft van Huijsduijnen, O., and Doyle, P. 1992. The importance of the brain in the aetiology of obesity and type 2 diabetes. Int. J. Obesity 16:S9-S12.
16. Kida, S., Pantazis, A., and Weller, R. O. 1993. CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathol. Appl. Neurobiol. 19:480-488.
17. Kreitman, R. J., Fitzgerald, D., and Pastan, I. 1992. Targeting growth factor receptors with fusion toxins. Int. J. Immunopharmacol. 14:465-472.
18. Kristensson, K., and Olsson, Y. 1971. Uptake of exogenous proteins in mouse olfactory cells. Acta Neuropath. (Berl.) 19:145-154.
19. Krompecher, I., Fornet, B., Földes, I., Hadházy, Cs., Orosz, Á., Kósa, C., Tóth, G., Hankiss, J., Filipp, G., Köver, B., and Kecskés, J. 1954. Zusammenhang des Saftkreislaufes der Nasenschleimhaut mit dem der Schädelhöhle bzw. dem Liquor. Acta. Physiol. Hung. 6:56-58.
20. Orosz, Á., Földes, I., Cósa, C., and Tóth, G. 1957. Radioactive isotope studies of the connection between the lymph circulation of the nasal mucosa, the cranial cavity and cerebrospinal fluid. Acta. Physiol. Acad. Sci. Hung. 11:75-81.
21. Pardridge, W. M. 1986. Receptor-mediated peptide transport through the blood-brain barrier. Endocr. Rev. 7:314-330.
22. Pardridge, W. M. 1996. Brain drug delivery and blood-brain barrier transport. Drug Deliv. 3:99-115.
23. Pardridge, W. M., Eisenberg, J., and Yang, J. 1985. Human blood-brain barrier insulin receptor. J. Neurochem. 44:1771-1778.
24. Pardridge, W. M., Kang, Y.-S., and Buciak, J. L. 1994. Transport of human recombinant brain-derived neurotropic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm. Res. 11:738-746.
25. Perl, D. P., and Good, P. F. 1987. Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet 1:1028.
26. Sakane, T., Akizuki, M., Yoshida, M., Yamashita, S., Nadai, T., Hashida, M., and Sezaki, H. 1991a. Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity. J. Pharm. Pharmacol. 43:449-451.
27. Sakane, T., Akizuki, M., Yamashita, S., Nadai, T., Hashida, M., and Sezaki, H. 1991b. The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: The relation to the lipophilicity of the drug. Chem. Pharm. Bull. 39:2456-2458.
28. Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C., and Porte, D. Jr. 1992. Insulin in the brain: A hormonal regulator of energy balance. Endocr. Rev. 13:387-114.
29. Seki, T., Sato, N., Hasegawa, T., Kawaguchi, T., and Juni, K. 1994. Nasal absorption of zidovudine and its transport to cerebrospinal fluid in rats. Biol. Pharm. Bull. 17:1135-1137.
30. Shipley, M. T. 1985. Transport of molecules from nose to brain: Transneuronal anterograde and retrograde labelling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium. Brain Res. Bull. 15:129-142.
31. Tolley, N. S., and Schwartz, P. 1991. Nose-blowing and CSF rhinorrhoea. Lancet 337:302.
32. Vanderweele, D. A., Pi-Sunyer, F. X., Novin, D., and Bush, M. J. 1980. Chronic insulin infusion suppresses food ingestion and body weight gain in rats. Brain Res. Bull. 5:7-11.
33. Van Dijk, G., de Groote, C., Chaves, M., van der Werf, Y., Steffens, A. B., and Strubbe, J. H. 1995. Insulin in the arcuate nucleus of the hypothalamus reduces overnight fat consumption in rats. In Central and Peripheral Mechanisms Involved in Fuel Homeostasis Febodruk BV (University of Groningen), The Netherlands, Van Diek, G., PhD thesis.
34. Williams, G., McKibbin, P. E., and McCarthy, H. D. 1991. Hypothalamic regulatory peptides and the regulation of food intake and energy balance: Signals or noise? Proc. Nutrit. Soc. 50:527-544.
35. Woods, S. C., Lotter, E. C., McKay, L. D., and Porte, D. Jr. 1979. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282:503-505.